Abstracts by keywords: Biomarkers
At the beginning of 2020, the "Interdisciplinary discussion forum on ethical, economic and medical challenges before the onset of dementia" was established in order to establish the public discussion on fundamental topics regarding diagnostics, therapy and care of dementia patients, which show a concrete need for action. found together. Current developments in the therapeutic field are discussed as well as ethical problems, gaps in care and special topics such as the use of biomarkers for risk stratification of patients in the early diagnosis of Alzheimer's disease.
05.06.2023
The growing global burden of cancer demands a more productive and efficient process for developing new therapies. The relatively low attrition rates of molecularly targeted cancer therapies suggest that efforts to accelerate development must start with a strong foundation of data and consensus methods for identifying biomarkers associated with cancer progression and treatment response. In addition, work is needed to improve the efficiency and consistency of trials in identifying therapies that meaningfully improve outcomes. Delivering on the promise of 21st Century cancer care will require a collaborative effort that engages all stakeholders in the cancer community - researchers, product developers, regulators, and patients.